Medisca's Hair Care Compounding Solutions

Download in electronic PDF format for $25

Search the Complete Journal Archives

Chronic Neuropathic Pain: Pharmacological Interventions in New Millennium

Author(s):  Jones Marty

Issue:  Jan/Feb 2000 - Compounding for Pain Management
View All Articles in Issue

Abstract:  Recent reports of N-methyl-D-aspartate receptor antagonists, glutamate antagonists, alpha2-agonists, gamma-aminobutyric acid agonists, alpha1-antagonists, opioids and antioxidants in various combinations provide the contemporary rationale that is furnishing increased efficacy in the clinical management of chronic neuropathic pain, with fewer side effects. This article focuses on this new theory as an approach, from the perspective of a compounding pharmacist, to provide better control of chronic neuropathic pain in the new millennium. Implementation of this theory in daily practice within the triad of care will enhance the odds of positive outcomes in patients suffering from chronic neuropathic pain. The author focuses on pathophysiology, evidence, a new approach and clinical compounding success. He concludes that this is a huge market and that the efficacy is significant using the approach presented in this article.

Related Keywords: allodynia, amantadine, AMPA receptors, baclofen, carbamazepine, clonidine, compounding, DermiGel, dermis, dextromethorphan, diabetic peripheral neuropathy, epidermis, fibromyalgia, free radicals, GABA receptors, gapabentin, HbA1c, hyperalgesia, ketamine, memantine, neuropathic pain, nifedipine, NMDA receptors, opioids, opium, orphenadrine, pain, pain management, phenytoin, PLO, postherpetic neuralgia, prazosin, reflex sympathetic dystrophy, speed gel, tricyclic antidepressants, valproic acid, VanPen, dermatome


Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Chronic Neuropathic Pain: Pharmacological Interventions in New Millennium Jones Marty Jan/Feb 2000 6 Buy
Transdermal Gels in the Treatment of Diabetic Neuropathy Hodges Caroline J, Jones Thomas H, Willoughby David L Mar/Apr 2000 91 Buy
Profile of a Practice: Ward Drug Company Diabetic Shoppe and Prescription Compounding Center Vail Jane Jan/Feb 2003 21 Buy
Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Allen Loyd V Jr May/Jun 2016 231 Buy
Book Review: The NMDA Receptor Jones Marty Jan/Feb 2000 26-27 Buy
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D May/Jun 2004 181 Buy
Case Report: Wound Care of a Diabetic Foot Ulcer Wynn Tom Jul/Aug 2004 265 Buy
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso Jul/Aug 2014 278-286 Buy
Dextromethorphan, an NMDA receptor antagonist, as a Treatment for Pain Mishkan Emilyn S Sep/Oct 2005 339-346 Buy
The Role of Sex Hormones on Fibromyalgia Pain Mediators Bramwell Bethany L May/Jun 2010 193-199 Buy